The circadian system is the body's master clock, organized around the suprachiasmatic nucleus (SCN) of the hypothalamus and entrained primarily by light exposure to the retina. The system governs not only sleep-wake timing but also the rhythmic regulation of cortisol, body temperature, immune function, metabolic activity, and gene expression across essentially every tissue in the body. The clinical implication for longevity psychiatry is that circadian disruption is not just a sleep problem; it is a system-level disruption with consequences across the substrate.
Shift work and night work are unambiguous cognitive risk factors. Decades of epidemiological work have linked chronic shift work — particularly rotating shifts and night shifts — to elevated risk of cardiovascular disease, metabolic dysfunction, cancer, and (the relevant finding for this volume) cognitive decline and dementia. The mechanism includes chronic misalignment between behavioral activity and internal circadian timing, sleep loss, disrupted melatonin secretion, and the cumulative metabolic and inflammatory consequences. Clinical care for shift workers is a longevity-psychiatry sub-specialty in its own right — strategies to minimize the misalignment and the cumulative damage exist but are underused.
Sundowning in dementia is the late-afternoon-into-evening pattern of increased confusion, agitation, and behavioral disturbance seen in many patients with established dementia. The biology involves circadian disruption secondary to neurodegenerative damage to the SCN itself, combined with reduced bright light exposure, fatigue from cognitive demands of the day, and the loss of orienting cues as the environment darkens. Sundowning is not random behavioral deterioration; it is a recognizable circadian phenomenon that responds, in part, to circadian interventions — daytime bright light exposure, evening reduced stimulation, structured routine, and (where appropriate) timed melatonin.
Melatonin is widely used and frequently misused. The endogenous hormone signals darkness to the SCN; supplemental melatonin is effective for circadian-misalignment interventions (jet lag, shift work, delayed sleep phase) and is modestly effective for primary insomnia in some populations, particularly older adults whose endogenous melatonin secretion has declined. Dosing reality: most over-the-counter melatonin products contain doses (3–10mg) substantially higher than what is physiologically optimal (often 0.3–1mg is more effective, particularly for sleep onset). Higher doses can produce next-day grogginess and may paradoxically disrupt sleep architecture. Quality varies enormously across OTC products — some preparations contain wildly different doses than labeled. Pharmaceutical-grade melatonin or low-dose preparations from reputable manufacturers are the clinical recommendation.
Light therapy is among the most evidence-supported and underused interventions. Morning bright light exposure (10,000 lux for 20–30 minutes, or equivalent natural sunlight) is well-established as a treatment for seasonal affective disorder, circadian rhythm disorders, and shift work adaptation. It is also clinically useful in elderly patients with disrupted sleep patterns, in patients with sundowning, in adolescents with delayed sleep phase, and in many cases of treatment-resistant depression with circadian features. The intervention is low-cost, well-tolerated, and underprescribed — most patients who would benefit are unaware that bright light therapy is a legitimate clinical intervention rather than a wellness trend.
Jet lag and travel produce predictable circadian disruption that can be managed with reasonable protocols. Pre-departure light timing adjustment, strategic caffeine and melatonin use during the trip, and aggressive bright light exposure at the destination together reduce adaptation time substantially. Frequent travelers — corporate executives, performers, athletes — are a population for whom circadian management is part of practice optimization. The clinical conversation often includes both jet lag protocols and the longer-term cognitive implications of chronic travel-related circadian disruption.
Chronotype — the genetically influenced preference for earlier or later sleep timing — is real, partly modifiable, and clinically relevant. Forcing a strong evening chronotype into early-morning work produces chronic mild circadian misalignment with cumulative cognitive and metabolic cost; supporting alignment between work and chronotype, where possible, reduces this cost. The clinical conversation includes recognition of chronotype as a stable individual characteristic rather than a moral question, and where misalignment exists, the question of whether the work or the timing can be adjusted to reduce the chronic mismatch.